0
Chest Infections |

Antibiotic Stewardship in Small Community Hospital

George Udeani, PharmD; Salim Surani, MD
Author and Funding Information

Texas A&M University, Corpus Christi, TX


Chest. 2014;145(3_MeetingAbstracts):146A. doi:10.1378/chest.1829321
Text Size: A A A
Published online

Abstract

SESSION TITLE: Respiratory Infections Posters

SESSION TYPE: Poster Presentations

PRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PM

PURPOSE: Linezolid is a novel oxazolidine antibiotic with activity against methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant enterococci (VRE) and penicillin-resistant Streptococcus pneumonia, besides activity against Clostridium perfingens, Clostridium difficle, Peptostreptococcus spp., and Bacteroides fragilis. With the emergence of multi-drug resistant organism efforts have been directed towards antibiotics stewardship. We conducted a retrospective chart review in a small community hospital to evaluate the pattern of use of linezolid based on institutional guidelines.

METHODS: Retrospective chart review of 25 patients who received linezolid after appropriate institutional review board approval was conducted. Clinical demographic data, as well as data on physician usage patterns of linezolid and other comparable antibiotics were collected. Cost analysis summary was also carried out.

RESULTS: Mean patient age was 60.88 +/- 16.93 and mean creatinine was 0.97mg/dl +/- 0.74. Majority of linezolid usage was for cellulitis. Only 2 patients with VRE and 2 patients with Vancomycin allergy and one patient with renal transplant qualified for linezolid based on the institutional guidelines. 20 out of 25 patients treated with linezolid qualified for other forms of therapy for the management of gram positive infections. Cost of Linezolid was $22,417 versus $2995 for Vancomycin and monitoring cost.

CONCLUSIONS: In the era of rising health care cost, physicians need to explore other cost effective modality of therapy, and moreover the newer antibiotics effective against resistant organism should be used judiciously to prevent the emergence of resistance against those antibiotics.

CLINICAL IMPLICATIONS: Physicians need to be continuously educated regarding antibiotic stewardship and institutional policies regarding antibiotics need to be designed.

DISCLOSURE: The following authors have nothing to disclose: George Udeani, Salim Surani

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Guidelines
Feverish illness in children: assessment and initial management in children younger than 5 years.
National Collaborating Centre for Women's and Children's Health | 8/28/2009
Blepharitis.
American Academy of Ophthalmology | 6/5/2009
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543